
Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review
Description
Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Sartorius Stedim Biotech SA (SSB) is a supplier of equipment and services to biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification, and cell cultivation. Its major products include laboratory balances, OEM weigh cells, mass comparators, weight sets, lab water systems, pipettes, fermentators, moisture analyzers, bioreactors, filters, shakers, virus purification kits and centrifuges, among others. SSB’s services include bioprocess development and engineering, protein expression systems, media and process, instrument and validation services. The company’s products find application in the production process of medicines in biopharmaceutical and pharmaceutical industries. SSB sells products through direct sales force in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. SSB is headquartered in Aubagne, France.
Sartorius Stedim Biotech SA Key Recent Developments
Jul 29,2025: Bio Usawa Biotechnology and Sartorius Stedim Biotech Enter Into Partnership
Jul 09,2025: Sartorius Stedim Biotech and Sensible Biotechnologies Sign Memorandum of Understanding
Jun 17,2025: Sartorius expands manufacturing and R&D capacities for innovative bioprocess solutions in France
Feb 17,2025: Sartorius Releases Annual Report Financial Results for 2024 Read Media Release
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Sartorius Stedim Biotech SA (SSB) is a supplier of equipment and services to biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification, and cell cultivation. Its major products include laboratory balances, OEM weigh cells, mass comparators, weight sets, lab water systems, pipettes, fermentators, moisture analyzers, bioreactors, filters, shakers, virus purification kits and centrifuges, among others. SSB’s services include bioprocess development and engineering, protein expression systems, media and process, instrument and validation services. The company’s products find application in the production process of medicines in biopharmaceutical and pharmaceutical industries. SSB sells products through direct sales force in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. SSB is headquartered in Aubagne, France.
Sartorius Stedim Biotech SA Key Recent Developments
Jul 29,2025: Bio Usawa Biotechnology and Sartorius Stedim Biotech Enter Into Partnership
Jul 09,2025: Sartorius Stedim Biotech and Sensible Biotechnologies Sign Memorandum of Understanding
Jun 17,2025: Sartorius expands manufacturing and R&D capacities for innovative bioprocess solutions in France
Feb 17,2025: Sartorius Releases Annual Report Financial Results for 2024 Read Media Release
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
56 Pages
- Section 1 - About the Company
- Sartorius Stedim Biotech SA - Key Facts
- Sartorius Stedim Biotech SA - Key Employees
- Sartorius Stedim Biotech SA - Key Employee Biographies
- Sartorius Stedim Biotech SA - Major Products and Services
- Sartorius Stedim Biotech SA - History
- Sartorius Stedim Biotech SA - Company Statement
- Sartorius Stedim Biotech SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Sartorius Stedim Biotech SA - Business Description
- Geographical Segment: Americas
- Performance
- Geographical Segment: Asia Pacific
- Performance
- Geographical Segment: EMEA
- Performance
- R&D Overview
- Sartorius Stedim Biotech SA - Corporate Strategy
- Sartorius Stedim Biotech SA - SWOT Analysis
- SWOT Analysis - Overview
- Sartorius Stedim Biotech SA - Strengths
- Sartorius Stedim Biotech SA - Weaknesses
- Sartorius Stedim Biotech SA - Opportunities
- Sartorius Stedim Biotech SA - Threats
- Sartorius Stedim Biotech SA - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- Sartorius Stedim Biotech SA, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Jul 29, 2025: Bio Usawa Biotechnology and Sartorius Stedim Biotech Enter Into Partnership
- Jul 09, 2025: Sartorius Stedim Biotech and Sensible Biotechnologies Sign Memorandum of Understanding
- Jun 17, 2025: Sartorius expands manufacturing and R&D capacities for innovative bioprocess solutions in France
- Feb 17, 2025: Sartorius Releases Annual Report Financial Results for 2024 Read Media Release
- Nov 21, 2024: Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA
- Nov 21, 2024: Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA
- Oct 17, 2024: Sartorius Stedim Biotech Publishes Unaudited Results for the First Nine Months of 2024
- Apr 18, 2024: Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Sartorius Stedim Biotech SA, Key Facts
- Sartorius Stedim Biotech SA, Key Employees
- Sartorius Stedim Biotech SA, Key Employee Biographies
- Sartorius Stedim Biotech SA, Major Products and Services
- Sartorius Stedim Biotech SA, History
- Sartorius Stedim Biotech SA, Subsidiaries
- Sartorius Stedim Biotech SA, Key Competitors
- Sartorius Stedim Biotech SA, Ratios based on current share price
- Sartorius Stedim Biotech SA, Annual Ratios
- Sartorius Stedim Biotech SA, Annual Ratios (Cont...1)
- Sartorius Stedim Biotech SA, Annual Ratios (Cont...2)
- Sartorius Stedim Biotech SA, Interim Ratios
- Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- Sartorius Stedim Biotech SA, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Sartorius Stedim Biotech SA, Performance Chart (2020 - 2024)
- Sartorius Stedim Biotech SA, Ratio Charts
- Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.